As such, more than fifty clinical trials are being performed in humans (https://www.clinicaltrials.gov/ (accessed on 16 April 2023) to study the possibility that apelin could be used for the treatment of cardiovascular diseases. This evidence concerns the gene APLN and cardiovascular disorder.